You are here

  • Home
  • Archive
  • Volume 21, Issue 2
  • Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

Article metrics

Article menu
Download PDFPDF
Cooperative Groups
Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 20196803
Apr 201916503
May 2019175010
Jun 201910202
Jul 201919201
Aug 201917305
Sep 201914305
Oct 201917402
Nov 201915504
Dec 201915504
Jan 2020279012
Feb 2020396018
Mar 202026803
Apr 2020419013
May 202030207
Jun 202020705
Jul 202030704
Aug 202023706
Sep 202036907
Oct 202026405
Nov 202020703
Dec 202023405
Jan 2021188014
Feb 202117405
Mar 202130406
Apr 2021289010
May 202116005
Jun 20211105
Jul 20211102
Aug 202110011
Sep 202111012
Oct 2021289012
Nov 202122506
Dec 202138609
Jan 202220708
Feb 202219005
Mar 202229108
Apr 2022217015
May 202238306
Jun 202220806
Jul 202220206
Aug 202239708
Sep 2022338010
Oct 2022369013
Nov 2022267019
Dec 202239105
Jan 2023536010
Feb 2023515014
Mar 202356508
Apr 202378509
May 2023695010
Jun 202392405
Jul 2023737022
Aug 2023391015
Sep 2023237011
Oct 2023350025
Nov 2023447017
Dec 2023383012
Jan 2024263011
Feb 202426807
Mar 2024462028
Apr 2024397014
Total184640551